Assessing Department-specific Antibiotic Susceptibility to Guide Selection and Improve Outcomes: Management of cUTIs is organized by Academy for Continued Healthcare Learning (ACHL).
Release Date: Aug 12, 2019
Expires on: Aug 12, 2020
The Academy for Continued Healthcare Learning designates this enduring material for a maximum of .50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
A faculty panel discuss a cases relating to the assessment and treatment of cUTIs. Topics include emerging technologies for diagnosis, common pathogens, and the selection of therapy for resistant gram-negative infections.
Upon completion of the activity, participants should be able to:
• Discuss the molecular epidemiology of antibiotic resistance in bacterial pathogens
• Compare and contrast antibiotics currently in development for use against gram-negative pathogens
• Describe strategies to optimize antimicrobial therapy to ensure effectiveness of antibiotics and reduce resistance
Additional details will be posted as soon as information is available.
This activity is intended for ID specialists, researchers, clinical microbiologists, hospitalists, internists, pharmacists and other healthcare professionals who care for patients at risk of serious infection.